The trends in the expression of the four hub genes were consistent and significant in both the training and validation sets, except for MYH6, which was expressed at lower levels in the DCM group, whereas the expression of the other three genes was higher in the DCM group than in the control group. The gene discussed is MYH6; the disease is familial dilated cardiomyopathy.